- Business Type:
- Manufacturer
- Year Established:
- 2014
- Total Revenue:
- US$50 Million - US$100 Million
- Main Products:
- Imazethapyr, Imazapic, Imazameth, 2-Chloronicotinic Acid, Butanamide, Butyramide,<br /> 23-Dichcloropyridine, Dimethyl 5-Methylpyridine-23-Dicarboxylate
Product Showcase
-
2-amino-2,3-dimethyl butyrylamide
-
dimethyl 5-methylpyridine-2,3-dicarboxylate
-
5-ethylpridine-2,3-dicarboxylic acid diethy ester
-
2-chloronicotinic acid
-
spirotetramat intermediate
Contacts
- Ms. Amy